Involvement of Transglutaminase-2 in Pathological Changes in Renal Disease

Publisher： Karger

E-ISSN： 1660-2110|105|3|c139-c146

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.105, Iss.3, 2007-01, pp. : c139-c146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Treatment with Corticosteroids and Cyclosporine Reduce Transglutaminase Type 2 Expression in the Renal Tissue of Patients with Membranous Nephropathy?

By  

Nephron Clin Pract, Vol. 121, Iss. 1-2, 2012-10 ,pp. : c60-c67

Karger

Access to resources Recommend Favorite

Intestinal anti‐transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 3, 2018-03 ,pp. : 311-317

John Wiley & Sons Inc

Access to resources Recommend Favorite

APOEε2 is associated with milder clinical and pathological Alzheimer disease

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 6, 2015-06 ,pp. : 917-929

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Pathological View of Disease

By Stempsey W.E.  

Theoretical Medicine, Vol. 21, Iss. 4, 2000-08 ,pp. : 321-330

Springer Publishing Company

Access to resources Recommend Favorite

Pathological polyploidy in liver disease

By  

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 968-970

John Wiley & Sons Inc

Access to resources Recommend Favorite